
Corporate M&A
Capital Markets
Corporate Governance
Technology Transactions
Emerging Companies & Growth
Public Company Representation
Healthcare & Life Sciences
Cheston J. Larson is a Partner at Latham & Watkins, based in San Diego, California. He specializes in a broad range of corporate matters, including mergers and acquisitions, capital markets, and corporate governance. Cheston advises both public and private companies, as well as venture capital and investment banking firms, on financing transactions. His expertise extends to the life sciences, software, telecommunications, and cleantech industries. With a JD from Harvard Law School, where he was an editor of the Harvard Law Review, Cheston is a frequent speaker on IPO and securities law-related topics. He has a proven track record in guiding clients through complex transactions and compliance matters.
- eFFECTOR Therapeutics, Inc. acted as the seller in this Financing transaction. - The divestment involved assets operating in the Healthcare sector. - The transaction was announced on 26 May 2023 with a reported value of 75000000.0.
May 26 2023
75M
Finance
Partner
2016 – Unknown

- Merck acquired Prometheus Biosciences from Prometheus Biosciences in a acquisition on 2023-04-17. - Deal value was 108000000000 (source: Extracted) Ownership: 100% acquisition; Location: USA. - On the acquirer side, Paul, Weiss advised, led by Laura Turano, Scott Barshay, Jennifer Wang.
Apr 17 2023
11B
M&A
1 min